Analysts are on the Bearish side about Medtronic plc (NYSE:MDT) this week.

October 10, 2018 - By Ash

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 0.98 in 2018 Q2. Its down 0.10, from 1.08 in 2018Q1. It is negative, as 49 investors sold Medtronic plc shares while 436 reduced holdings. 99 funds opened positions while 374 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2018Q1 were reported.
Auxier Asset Mgmt reported 2.73% stake. Strategic Fincl invested in 57,707 shares or 0.76% of the stock. Buckingham Asset Ltd Co owns 5,506 shares for 0.08% of their portfolio. Conning invested 0.32% in Medtronic plc (NYSE:MDT). State Board Of Administration Of Florida Retirement System has 0.43% invested in Medtronic plc (NYSE:MDT) for 1.88 million shares. The California-based Aperio Ltd Limited Liability Company has invested 0.2% in Medtronic plc (NYSE:MDT). Piedmont Invest Lc has 0.24% invested in Medtronic plc (NYSE:MDT). Panagora Asset Mgmt accumulated 48,129 shares. Spirit Of America Mngmt Corp owns 0.1% invested in Medtronic plc (NYSE:MDT) for 9,029 shares. Haverford accumulated 1.08 million shares. Canada Pension Plan Investment Board accumulated 0.36% or 2.19 million shares. Edge Wealth Mngmt Limited Liability Corp owns 12,240 shares. Twin Tree Mngmt L P has 2,378 shares. Vantage Inv Advsr Ltd Liability Co holds 1.59% of its portfolio in Medtronic plc (NYSE:MDT) for 76,610 shares. Trust Of Oklahoma stated it has 0% in Medtronic plc (NYSE:MDT).

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 12 analysts covering Medtronic (NYSE:MDT), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Medtronic had 17 analyst reports since April 27, 2018 according to SRatingsIntel. Piper Jaffray initiated the shares of MDT in report on Friday, April 27 with “Buy” rating. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Argus Research on Monday, October 8. On Wednesday, June 6 the stock rating was maintained by Bank of America with “Buy”. The firm has “Market Perform” rating given on Wednesday, June 6 by William Blair. The firm has “Buy” rating by Bank of America given on Wednesday, August 22. As per Wednesday, August 22, the company rating was maintained by Morgan Stanley. The company was maintained on Friday, May 25 by Morgan Stanley. On Wednesday, August 22 the stock rating was maintained by BMO Capital Markets with “Outperform”. Citigroup maintained Medtronic plc (NYSE:MDT) on Friday, August 24 with “Buy” rating. As per Wednesday, August 22, the company rating was maintained by Stifel Nicolaus. Below is a list of Medtronic plc (NYSE:MDT) latest ratings and price target changes.

08/10/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $108 New Target: $120 Maintain
27/08/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $95 New Target: $108 Maintain
24/08/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $104 New Target: $109 Maintain
22/08/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $98 New Target: $105 Maintain
22/08/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $94 New Target: $104 Maintain
22/08/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $95 New Target: $101 Maintain
22/08/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $87 New Target: $96 Maintain
22/08/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $95 New Target: $105 Maintain
13/08/2018 Broker: Needham Old Rating: Buy New Rating: Strong Buy Old Target: $103 New Target: $119 Upgrade
27/06/2018 Broker: Bernstein Rating: Market Perform New Target: $88 Initiates Coverage On

The stock decreased 0.69% or $0.66 during the last trading session, reaching $95.53. About 2.96 million shares traded. Medtronic plc (NYSE:MDT) has risen 16.95% since October 10, 2017 and is uptrending. It has outperformed by 1.33% the S&P500.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $129.01 billion. The companyÂ’s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 41.19 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

Another recent and important Medtronic plc (NYSE:MDT) news was published by Fool.com which published an article titled: “Why Mazor Robotics Ltd. Stock Popped 20.6% in September” on October 10, 2018.

Medtronic plc (NYSE:MDT) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>